|
Practice/Industry Group Overview
Buchanan Ingersoll & Rooney regularly advises a range of clients in the chemical industry on intellectual property and technology commercialization issues. Our attorneys have handled particularly intricate product liability, environmental, regulatory and other related matters for chemical manufacturers, research and development entities and universities, and chemical treatment businesses.
Our Chemical Practice Group has worked with clients on cutting edge technologies in pharmaceuticals, including sophisticated synthetic pathways to small molecular entities, proteomics, drug delivery and polymers, including deliverable polymeric compositions for treating vascular diseases. We also have experience in petroleum refining, including recent discoveries in recovery of naturally occurring diamondoids from petroleum feedstocks, and in polymer chemistry, cosmetics and battery technologies.
In addition, our technical background helps clients with cross-disciplinary issues that arise at the interfaces between chemical technology and biochemistry, bioinformatics, medical devices, nanotechnology and neurology.
Our experience is particularly suited for developing patent strategies for the world market, including strategies adaptable for start-ups as well as multinational companies, and includes not only U.S. and worldwide patent prosecution but also recognized leadership in re-examination and interference proceedings at the USPTO.
|